Al-Mahtab, M.; Akbar, S.M.F.; Yoshida, O.; Aguilar, J.C.; Guillen, G.; Hiasa, Y.
Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon. Vaccines 2023, 11, 962.
https://doi.org/10.3390/vaccines11050962
AMA Style
Al-Mahtab M, Akbar SMF, Yoshida O, Aguilar JC, Guillen G, Hiasa Y.
Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon. Vaccines. 2023; 11(5):962.
https://doi.org/10.3390/vaccines11050962
Chicago/Turabian Style
Al-Mahtab, Mamun, Sheikh Mohammad Fazle Akbar, Osamu Yoshida, Julio Cesar Aguilar, Gerardo Guillen, and Yoichi Hiasa.
2023. "Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon" Vaccines 11, no. 5: 962.
https://doi.org/10.3390/vaccines11050962
APA Style
Al-Mahtab, M., Akbar, S. M. F., Yoshida, O., Aguilar, J. C., Guillen, G., & Hiasa, Y.
(2023). Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon. Vaccines, 11(5), 962.
https://doi.org/10.3390/vaccines11050962
